Ascendis Pharma Oncology Division A/S — Credit Rating and Financial Key Figures

Ascendis Pharma Oncology Division A/S (CVR number: 41034076) is a company from GENTOFTE. The company recorded a gross profit of -92475 kEUR in 2024. The operating profit was -92.6 mEUR, while net earnings were -106.4 mEUR. The profitability of the company measured by Return on Assets (ROA) was -27.1 %, which can be considered poor and Return on Equity (ROE) was -38264.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -100 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Ascendis Pharma Oncology Division A/S's liquidity measured by quick ratio was 7.1 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.